HSPA5 and prostate cancer: The confirmation that the immune responses of csGRP78 were channeled via two compartments was demonstrated first by the ability of specific N- or C-terminal anti-GRP78 sheep antibodies to induce different calcium signaling waves on csGRP78 prostate cancer cells [4].